Greg Blake
Follow
Get notifications in MyBN when activity occurs.
Greg Blake
Vice President & Global Head of Commercial & Partnering, Executive Director since 2023 / Zelira Therapeutics
Greg Blake has extensive commercial and operational leadership experience within the pharmaceutical and biotech sectors in Australia and internationally. He has led the strategic development and commercialisation of a number of products across a range of therapeutic categories.
During his 20 years of work in the healthcare sector, Mr Blake has built a solid foundation of knowledge across marketing and the entire commercial value chain. His work with Rhythm Biosciences as general manager led
the company through the establishment of the pre-launch critical pathway and commercialisation planning for the domestic and international markets. As marketing lead (Europe) of Mundipharma International, he successfully led 26 European countries through the pre-launch and launch phases for a novel pain medication. Mr Blake had also held leadership roles at large multinationals (J&J and CSL) and publicllisted biotech startups.
During his 20 years of work in the healthcare sector, Mr Blake has built a solid foundation of knowledge across marketing and the entire commercial value chain. His work with Rhythm Biosciences as general manager led
the company through the establishment of the pre-launch critical pathway and commercialisation planning for the domestic and international markets. As marketing lead (Europe) of Mundipharma International, he successfully led 26 European countries through the pre-launch and launch phases for a novel pain medication. Mr Blake had also held leadership roles at large multinationals (J&J and CSL) and publicllisted biotech startups.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 607th | Artrya | 4% | |
| 766th | Advanced Health Intelligence | -2% | -24% |
| 949th | Zelira Therapeutics | -14% | -38% |
| 1406th | Strategic Elements | -46% | 11% |
| 1720th | Roots Sustainable Agricultural Technologies | -67% | -62% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
2021
Vice President & Global Head of Commercial & Partnering, Executive Director since 2023
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 155th |  | Zelira Therapeutics | $1.6m |
| 170th |  | Artrya | $996k |
| 171st | | Strategic Elements | $855k |
| 173rd | | Advanced Health Intelligence | $772k |
| 174th |  | Roots Sustainable Agricultural Technologies | $630k |
201 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: Vice President & Global Head of Commercial & Partnering, Executive Director since 2023, Zelira Therapeutics | 20 Feb 2023 |
